Cargando…
A Randomised, Double-Blind, Controlled Vaccine Efficacy Trial of DNA/MVA ME-TRAP Against Malaria Infection in Gambian Adults
BACKGROUND: Many malaria vaccines are currently in development, although very few have been evaluated for efficacy in the field. Plasmodium falciparum multiple epitope (ME)– thrombospondin-related adhesion protein (TRAP) candidate vaccines are designed to potently induce effector T cells and so are...
Autores principales: | Moorthy, Vasee S, Imoukhuede, Egeruan B, Milligan, Paul, Bojang, Kalifa, Keating, Sheila, Kaye, Pauline, Pinder, Margaret, Gilbert, Sarah C, Walraven, Gijs, Greenwood, Brian M, Hill, Adrian S. V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524376/ https://www.ncbi.nlm.nih.gov/pubmed/15526058 http://dx.doi.org/10.1371/journal.pmed.0010033 |
Ejemplares similares
-
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
por: Ogwang, Caroline, et al.
Publicado: (2013) -
Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014) -
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
por: Afolabi, Muhammed O, et al.
Publicado: (2016) -
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
por: Bejon, Philip, et al.
Publicado: (2006) -
Prevention of the Recurrence of Anaemia in Gambian Children Following Discharge from Hospital
por: Bojang, Kalifa A., et al.
Publicado: (2010)